Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Common stock, par value $0.001 per share
-
Shares outstanding
-
148M
-
Number of holders
-
67
-
Total 13F shares, excl. options
-
32.5M
-
Shares change
-
+15.4M
-
Total reported value, excl. options
-
$105M
-
Value change
-
+$48M
-
Put/Call ratio
-
0
-
Number of buys
-
50
-
Number of sells
-
-35
-
Price
-
$3.22
Significant Holders of 89bio, Inc. - Common stock, par value $0.001 per share (ETNB) as of Q2 2022
94 filings reported holding ETNB - 89bio, Inc. - Common stock, par value $0.001 per share as of Q2 2022.
89bio, Inc. - Common stock, par value $0.001 per share (ETNB) has 67 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 32.5M shares
of 148M outstanding shares and own 21.89% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (7.78M shares), BVF INC/IL (3.9M shares), ORBIMED ADVISORS LLC (3.66M shares), JANUS HENDERSON GROUP PLC (1.69M shares), BOXER CAPITAL, LLC (1.4M shares), GREAT POINT PARTNERS LLC (1.4M shares), TCG Crossover Management, LLC (1.13M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.1M shares), CITADEL ADVISORS LLC (1.06M shares), and VANGUARD GROUP INC (988K shares).
This table shows the top 67 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.